DAFALGAN cpr 500 mg 100 pce
7680692660046
CH-69266
N02BE01
01.01.1.
1 / 3
google
Details
- Product number
- 6926601
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- paracetamolum 500 mg, hypromellosum, povidonum K 90, carmellosum natricum conexum corresp. natrium 2.07 mg, cellulosum microcristallinum, glyceroli dibehenas, magnesii stearas, pro compresso.
Articles (1)
Dafalgan 500 mg, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.07 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 15.70
Specialties list
Yes
Generic
No
SL addition date:
01/10/2025
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69266
- Drug name
- Dafalgan, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/03/2024
- Authorization expiration date
- 27/03/2029
- IT number
- 01.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN cpr 500 mg 100 pce
- Description (DE)
- DAFALGAN Tabl 500 mg 100 Stk
- Market launch
- 31/07/2025
- Narcotic (BTM)
- No